Alexander A.  Fitzpatrick net worth and biography

Alexander Fitzpatrick Biography and Net Worth

General Counsel of Evofem Biosciences
Alexander A. Fitzpatrick Esq., J.D. serves as Executive Vice President, General Counsel, Secretary of the Company. Mr. Fitzpatrick is responsible for our corporate governance, legal, corporate development, intellectual property and risk management functions. Prior to joining Evofem, Mr. Fitzpatrick served as Chief Legal Officer of Kyriba Corporation from 2014 to 2015 and Senior Vice President, General Counsel, Compliance Officer and Secretary of Verenium Corporation, a publicly traded biotechnology company from 2010 to 2014. Prior to that, Mr. Fitzpatrick served as Senior Vice President, General Counsel and Secretary of Kintera, Inc., a publicly traded technology company. Following the sale of Kintera, Mr. Fitzpatrick continued to serve in a similar position for a major division of Blackbaud, Inc. Prior to that, as a member of the business, corporate and technology departments with the law firms Cooley LLP and Latham & Watkins LLP in San Diego, and Rogers & Wells LLP (now Clifford Chance) in London, Mr. Fitzpatrick represented pharmaceutical and other technology companies, investment banks and venture capitalists in a variety of transactions including numerous collaborations, mergers and acquisitions, intellectual property matters, licensing and financing activity. Mr. Fitzpatrick received a B.S. in mathematics from Georgetown University and a J.D. from the University of California, Berkeley.

What is Alexander A. Fitzpatrick's net worth?

The estimated net worth of Alexander A. Fitzpatrick is at least $605.86 as of September 28th, 2023. Mr. Fitzpatrick owns 42,969 shares of Evofem Biosciences stock worth more than $606 as of April 19th. This net worth estimate does not reflect any other assets that Mr. Fitzpatrick may own. Learn More about Alexander A. Fitzpatrick's net worth.

How do I contact Alexander A. Fitzpatrick?

The corporate mailing address for Mr. Fitzpatrick and other Evofem Biosciences executives is 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. Evofem Biosciences can also be reached via phone at (858) 550-1900 and via email at [email protected]. Learn More on Alexander A. Fitzpatrick's contact information.

Has Alexander A. Fitzpatrick been buying or selling shares of Evofem Biosciences?

Alexander A. Fitzpatrick has not been actively trading shares of Evofem Biosciences within the last three months. Most recently, on Monday, December 20th, Alexander A. Fitzpatrick bought 200 shares of Evofem Biosciences stock. The stock was acquired at an average cost of $48.75 per share, with a total value of $9,750.00. Learn More on Alexander A. Fitzpatrick's trading history.

Who are Evofem Biosciences' active insiders?

Evofem Biosciences' insider roster includes Russell Barrans (Insider), Justin File (CFO), Alexander Fitzpatrick (General Counsel), Kim Kamdar (Director), Anthony O'Brien (Director), Saundra Pelletier (CEO), and Lisa Rarick (Director). Learn More on Evofem Biosciences' active insiders.

Alexander A. Fitzpatrick Insider Trading History at Evofem Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Buy200$48.75$9,750.00View SEC Filing Icon  
6/10/2021Buy80$127.50$10,200.002,491View SEC Filing Icon  
8/21/2018Buy40$276.25$11,050.00View SEC Filing Icon  
See Full Table

Alexander A. Fitzpatrick Buying and Selling Activity at Evofem Biosciences

This chart shows Alexander A Fitzpatrick's buying and selling at Evofem Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evofem Biosciences Company Overview

Evofem Biosciences logo
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.02

50 Day Range

MA: $0.02
Low: $0.01
High: $0.03

2 Week Range

Now: $0.01
Low: $0.01
High: $4.36

Volume

182,360 shs

Average Volume

845,148 shs

Market Capitalization

$760,836.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A